{"References": [{"title": "Statistical Evaluation of Surrogate Endpoints with Examples from Cancer Clinical Trials", "authors": "Marc Buyse, Tomasz Burzykowski, Geert Molenberghs, Ariel Alonso", "journal": "Biometrical Journal", "year": "2010", "volumes": "52", "first page": "104", "last page": "120", "DOI": "10.1002/bimj.200900067"}, {"title": "Surrogate End Points in Clinical Trials: Are We Being Misled?", "authors": "Thomas R. Fleming, David L. DeMets", "journal": "Annals of Internal Medicine", "year": "1996", "volumes": "125", "first page": "605", "last page": "613", "DOI": "10.7326/0003-4819-125-7-199610010-00011"}, {"title": "The Prentice Criteria for Surrogate Endpoints in the Context of Causal Inference", "authors": "Michael Elliott, Andrea Rotnitzky", "journal": "Biometrics", "year": "2013", "volumes": "69", "first page": "924", "last page": "935", "DOI": "10.1111/biom.12082"}, {"title": "Causal Inference for Surrogate Endpoints in Randomized Trials", "authors": "James M. Robins, Andrea Rotnitzky", "journal": "Biometrics", "year": "2004", "volumes": "60", "first page": "724", "last page": "732", "DOI": "10.1111/j.0006-341X.2004.00224.x"}, {"title": "Principal Stratification Approach to Causal Inference with Surrogate Endpoints", "authors": "Constantine Frangakis, Donald Rubin", "journal": "Biometrics", "year": "2002", "volumes": "58", "first page": "21", "last page": "29", "DOI": "10.1111/j.0006-341X.2002.00021.x"}, {"title": "The Surrogate Paradox: A Cautionary Tale", "authors": "David A. Freedman", "journal": "Journal of the American Statistical Association", "year": "2008", "volumes": "103", "first page": "139", "last page": "146", "DOI": "10.1198/016214507000000968"}, {"title": "Evaluation of Surrogate Endpoints in Randomized Experiments with Mixed Outcomes", "authors": "Michael Elliott, Andrea Rotnitzky, James M. Robins", "journal": "Biometrics", "year": "2008", "volumes": "64", "first page": "1156", "last page": "1164", "DOI": "10.1111/j.1541-0420.2007.00976.x"}, {"title": "Causal Association and Surrogate Endpoints in Clinical Trials", "authors": "Andrea Rotnitzky, James M. Robins", "journal": "Statistical Methods in Medical Research", "year": "2004", "volumes": "13", "first page": "3", "last page": "21", "DOI": "10.1191/0962280204sm351ra"}, {"title": "Surrogate Endpoints in Clinical Trials: Definition and Operational Criteria", "authors": "Ross L. Prentice", "journal": "Statistics in Medicine", "year": "1989", "volumes": "8", "first page": "431", "last page": "440", "DOI": "10.1002/sim.4780080407"}, {"title": "Causal Effectiveness and Surrogate Endpoints in Clinical Trials", "authors": "James M. Robins, Andrea Rotnitzky", "journal": "Journal of the American Statistical Association", "year": "2001", "volumes": "96", "first page": "408", "last page": "419", "DOI": "10.1198/016214501753168100"}]}